Successful Life Science Collaborations Require Flexibility

Law360, New York (February 21, 2013, 11:57 AM EST) -- It goes without saying that the process of getting innovative new medicines to patients is a long, complex and expensive undertaking. One of the ironies of the life sciences industry, however, is that small companies — the ones that don’t always have the time, money or global capabilities to develop and launch a new medicine on its own — are the source of much of the innovation in it.

Strategic partnering, therefore, is important. For emerging companies, it can provide capital, expertise and global reach that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.